Role of Tyrosine Kinase Inhibitors in Cancer Therapy

By A. Arora, E. Scholar. Journal of Pharmacology and Experimental Therapeutics, 2005

1,017 citations recorded by the source corpus.

Subfields: Hematology, Molecular Biology, Oncology

View Paper: https://www.semanticscholar.org/paper/667551621901f07b40b0610e92d46044160076c7

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Molecular Biology

1. K. Imai
2. A. Takaoka

In Oncology

1. K. Imai
2. A. Takaoka

Citations in the corpus

• In vivo delivery of miRNAs for cancer therapy: Challenges and strategies (2014, background): “It also displays the toxicity in rapidly dividing normal tissues such as the bone marrow and the gastrointestinal tract, resulting in side effects [2].”
• Comparing antibody and small-molecule therapies for cancer (2006, background): “Small-molecule agents for cancer therapy RTKs and non-RTKs are crucial mediators in signalling pathways of cell proliferation, differentiation, migration, angiogenesis, cell-cycle regulation and other”